Development and Evaluation of a Sea buckthorn Oil-based Nano-emulsion Gel for Enhanced Topical Drug Delivery
Junaid S Shaikh1*, Vasim T Pathan2
1Assistant Professor, Shree Sureshdada Jain Institute of Pharmaceutical Education and Research, Jamner.
2Associate Professor, Mahavir Institute of Pharmacy, Nashik, Maharashtra, India.
*Corresponding Author E-mail: skjunaid.pharm@gmail.com
ABSTRACT:
Topical drug delivery systems offer a targeted and non-invasive approach for treating dermatological conditions; however, the effectiveness of conventional formulations is often limited by poor drug penetration through the stratum corneum. The present study aimed to develop and evaluate a nano-emulsion-based gel containing sea buckthorn (Hippophae rhamnoides) oil to enhance topical delivery and therapeutic efficiency. Sea buckthorn oil was extracted using supercritical CO₂ extraction to preserve its bioactive constituents. Nano-emulsions were formulated using a surfactant blend of Tween 80 and Span 80, followed by high-speed homogenization and ultrasonication to achieve nanoscale droplets. The optimized nano-emulsion was further incorporated into a gel system using hydroxyethylcellulose and xanthan gum to improve application characteristics. The formulations were evaluated for physicochemical properties, including pH, viscosity, droplet size, polydispersity index, zeta potential, drug content, spreadability, thermodynamic stability, and in-vitro drug release. The developed nano-emulsion gel showed appropriate pH compatible with skin, high drug content (>97%), nanoscale droplet size (142–176 nm), and good stability with zeta potential values ranging from −32.4 to −36.2 mV. In-vitro diffusion studies demonstrated sustained and enhanced drug release, with the optimized formulation exhibiting maximum release of 93.8% within 8 hours. The results confirm that nano-emulsion gel significantly improves the stability, penetration, and release characteristics of sea buckthorn oil. Therefore, the developed nano-emulsion-based gel represents a promising and effective carrier system for topical delivery of natural bioactive compounds for dermatological applications.
KEYWORDS: Sea buckthorn oil, Nano-emulsion, Nano-emulsion gel, Topical drug delivery, Supercritical CO₂ extraction
1. INTRODUCTION
Topical drug delivery systems (TDDS) involve the administration of therapeutic agents directly onto the skin or mucous membranes for localized or systemic effects. This approach is widely used in dermatology, pain management, and hormone therapy due to its significant advantages over oral and injectable routes, including reduced systemic side effects, avoidance of hepatic first-pass metabolism, and improved patient compliance¹. Recent advancements in TDDS have focused on improving drug permeation across the skin barrier through innovative approaches such as nanotechnology-based carriers, microneedle systems, and bioengineered formulations, which enhance therapeutic effectiveness and targeted delivery².
The skin, particularly the outermost layer known as the stratum corneum, acts as a major barrier to drug absorption and limits the penetration of therapeutic agents. To overcome this barrier, researchers have developed advanced delivery systems, including lipid-based nanocarriers such as liposomes and solid lipid nanoparticles, as well as chemical penetration enhancers. These strategies improve drug permeation, stability, and bioavailability, thereby enhancing therapeutic outcomes³. Despite these advancements, several challenges remain, including skin irritation, variability in drug absorption due to individual skin differences, and formulation instability, which continue to be important areas of research in topical drug delivery⁴.
Nano-emulsions are thermodynamically stable colloidal systems composed of two immiscible phases, typically oil and water, stabilized by surfactants, with droplet sizes ranging between 20 and 200 nm⁵. Due to their small droplet size, large surface area, and enhanced stability, nano-emulsions have emerged as promising delivery systems for topical and transdermal applications. These systems improve the solubility of poorly water-soluble drugs, enhance drug penetration through the skin, and provide controlled drug release, making them highly suitable for dermatological therapy, fungal infections, and localized drug delivery⁶⁻⁸.
1.1 Advantages of Nano-emulsions in Topical Drug Delivery:
Nano-emulsions offer several advantages that make them highly suitable for topical drug delivery applications.
First, nano-emulsions enhance drug permeation through the skin due to their small droplet size, which increases the surface area and improves interaction with the skin surface. This enhanced interaction facilitates improved drug absorption and penetration into deeper skin layers⁹.
Second, nano-emulsions exhibit excellent physical stability compared to conventional emulsions. They resist instability phenomena such as sedimentation, flocculation, and coalescence, thereby improving shelf life and formulation stability³.
Third, nano-emulsions provide controlled and sustained drug release, which helps maintain therapeutic drug levels for an extended period and reduces the need for frequent application. This improves therapeutic effectiveness and reduces systemic side effects¹.
Fourth, nano-emulsions improve the solubility of lipophilic drugs, making them suitable for delivering poorly water-soluble compounds such as antifungal agents, retinoids, and natural phytoconstituents².
Finally, nano-emulsions are non-invasive and patient-friendly delivery systems, as they avoid needle-related discomfort and improve patient compliance, making them highly suitable for long-term dermatological therapy⁵.
Nano-emulsions also utilize advanced surfactant systems and emulsifiers widely employed in cosmetic formulations, improving formulation stability and skin compatibility¹⁰.
1.2 Disadvantages of Nano-emulsions:
Despite their numerous advantages, nano-emulsions also present certain limitations that must be carefully considered during formulation development.
One of the primary disadvantages is the requirement of high surfactant concentrations, which may cause skin irritation, toxicity, or hypersensitivity reactions if not properly optimized⁴.
Another limitation is the complexity of the manufacturing process. Nano-emulsion preparation requires precise control over formulation parameters, homogenization speed, and energy input, which increases formulation complexity and production challenges⁷.
Additionally, nano-emulsions are more suitable for lipophilic drugs and may have limited capacity to incorporate hydrophilic drugs effectively⁹.
Furthermore, the production of nano-emulsions using high-energy methods such as ultrasonication and high-pressure homogenization may increase manufacturing costs, limiting their large-scale commercial application³.
1.3 Methods of Preparation of Nano-emulsions:
Nano-emulsions can be prepared using high-energy or low-energy methods, depending on formulation requirements and desired characteristics.
1.3.1 High-Energy Methods:
High-energy methods utilize mechanical energy to reduce droplet size and form stable nano-emulsions.
High-pressure homogenization is a commonly used method in which the formulation is forced through a narrow valve at high pressure, resulting in droplet size reduction and uniform nano-emulsion formation⁵.
Ultrasonication is another widely used technique in which ultrasonic waves generate cavitation forces that break larger droplets into nanosized droplets, improving formulation stability and uniformity².
Microfluidization involves passing the emulsion through microchannels under high pressure, resulting in uniform droplet size and improved nano-emulsion stability¹.
1.3.2 Low-Energy Methods:
Low-energy methods rely on physicochemical properties of surfactants and formulation components rather than mechanical energy.
The phase inversion temperature method utilizes temperature-dependent changes in surfactant solubility to form stable nano-emulsions⁴.
Spontaneous emulsification involves mixing oil, surfactant, and aqueous phases, resulting in spontaneous nano-emulsion formation due to interfacial turbulence⁹.
Solvent displacement method involves dissolving oil and surfactant in a water-miscible solvent, followed by solvent evaporation, resulting in nano-emulsion formation³.
2. DRUG PROFILE:
2.1 Synonyms and Nomenclature:
Sea buckthorn (Hippophae rhamnoides) is commonly known by several names, including sandthorn, Siberian pineapple, and seaberry. It is also referred to by scientific synonyms such as Hippophae littoralis and Rhamnoides hippophae, reflecting its taxonomic classification and geographical diversity¹⁵.
2.2 Biological Source and Habitat:
Sea buckthorn belongs to the family Elaeagnaceae and is widely distributed across Europe and Asia. Various parts of the plant, including berries, seeds, leaves, and pulp oil, are utilized for medicinal, pharmaceutical, and cosmetic purposes. The plant is well adapted to harsh environmental conditions and typically grows in cold, arid, and high-altitude regions, where it develops a rich profile of bioactive compounds that contribute to its therapeutic properties²⁰,²⁴.
2.3 Chemical Constituents:
Sea buckthorn is a rich source of biologically active compounds that contribute to its pharmacological and therapeutic effects. The seed and pulp oil contain essential fatty acids such as palmitic acid, oleic acid, linoleic acid, and α-linolenic acid, which play important roles in skin regeneration and barrier repair²².
In addition, sea buckthorn is rich in vitamins, particularly vitamin C (ascorbic acid), vitamin E (tocopherols), and carotenoids such as β-carotene and lycopene, which exhibit strong antioxidant properties and protect the skin from oxidative damage²¹.
The plant also contains flavonoids and phenolic compounds, including quercetin, isorhamnetin, and kaempferol, which contribute to its anti-inflammatory, antioxidant, and protective effects against cellular damage²¹.
Furthermore, phytosterols such as β-sitosterol and campesterol are present in sea buckthorn oil, which help improve skin barrier function, reduce inflammation, and promote tissue repair²⁴.
2.4 Pharmacological and Therapeutic Uses:
2.4.1 Medicinal Applications:
Sea buckthorn oil has been widely studied for its therapeutic potential in various medical applications. It plays a significant role in skin health by promoting wound healing, accelerating tissue regeneration, reducing inflammation, and protecting against ultraviolet (UV)-induced skin damage²².
It also provides cardiovascular benefits by helping reduce low-density lipoprotein (LDL) cholesterol levels and improving overall heart health, thereby contributing to cardiovascular protection²⁰.
In addition, sea buckthorn exhibits strong anti-inflammatory and antioxidant properties, which make it useful in the management of inflammatory disorders, oxidative stress, and degenerative diseases²¹.
Sea buckthorn oil has also demonstrated beneficial effects on gastrointestinal health, including the treatment of gastric ulcers and improvement of gut microbiota balance, contributing to improved digestive function²².
2.4.2 Cosmetic and Nutraceutical Applications:
Sea buckthorn oil is widely used in cosmetic formulations due to its skin-nourishing and regenerative properties. It is commonly incorporated into anti-aging creams, moisturizers, and dermatological formulations to improve skin hydration, elasticity, and protection against oxidative damage²².
In addition, sea buckthorn is used as a nutraceutical supplement due to its high content of omega-3, omega-6, omega-7 fatty acids, vitamins, and antioxidants, which support overall health and wellness²⁰.
3. MATERIAL AND METHOD:
Hydroxyethylcellulose, phosphatidylcholine, tocopherol (vitamin E), rosemary extract, ethylhexylglycerin, and phenoxyethanol reagents were procured from Jinendra Scientific, Jalgaon. The remaining chemicals were obtained from the research laboratory of Pharmaceutics at SSJIPER, Jamner.
Collection of plant:
Fresh sea buckthorn (Hippophae rhamnoides) fruits were collected from Ladakh, India, during a field excursion. The harvested fruits were thoroughly washed, vacuum-sealed, and stored at –18°C to preserve their integrity.
3.1. Method for extraction of oil:
Supercritical CO₂ Extraction:
The selected supercritical CO₂ extraction method is widely reported for efficient recovery of bioactive compounds and antioxidant-rich sea buckthorn oil²⁵.
1. Sample Preparation:
· Fresh sea buckthorn fruits are washed, freeze-dried (lyophilized), and ground into powder (particle size ≤ 0.5mm).
· Moisture content: <5% (to prevent ice formation during extraction).
2. Extraction Parameters (CO₂-Based):
· Pressure: 250–350bar
· Temperature: 40–50°C
· O₂ flow rate: 10–20g/min
· Time: 2–4hours (yield: 8–12% w/w)
· Co-solvent: Ethanol (5–10%) to enhance carotenoid extraction
3. Post-Processing:
· Separate oil from CO₂ using a cyclone separator
· Filter through a 0.22μm membrane to remove particulates
· Store under nitrogen at −20°C to prevent oxidation
3.2 Formulation:
Table 1. Formulation
|
Sr. No. |
Ingredients |
F1 Concentration (%W/V) |
F2 Concentration (%W/V) |
F3 Concentration (%W/V) |
Uses |
|
1 |
Sea Buckthorn oil |
7 |
8 |
9 |
Antioxidant |
|
2 |
Tween 80 + Span 80 |
6 (4:2) |
6 (4:2) |
6 (4:2) |
Surfactant Blend |
|
3 |
Xanthan Gum |
0.2 |
0.2 |
0.2 |
Thickener |
|
4 |
Hydroxyethylcellulose |
0.15 |
0.15 |
0.15 |
Thickener |
|
5 |
phosphatidylcholine |
1.5 |
1.5 |
1.5 |
Co-Emulsifier |
|
6 |
Glycerol |
3 |
3 |
3 |
Humectant |
|
7 |
Propylene glycol |
1 |
2 |
3 |
Penetration enhancer |
|
8 |
Tocopherol |
0.1 |
0.1 |
0.1 |
Antioxidant |
|
9 |
Rosemary Extract |
0.1 |
0.1 |
0.1 |
Antioxidant |
|
10 |
Citric Acid |
0.12 |
0.12 |
0.12 |
Maintain PH (5.8-6.2) |
|
11 |
Sodium Citrate |
0.25 |
0.25 |
0.25 |
Maintain PH (5.8-6.2) |
|
12 |
Ethylhexylglycerin |
0.3 |
0.3 |
0.3 |
Preservative |
|
13 |
Phenoxyethanol |
0.3 |
0.3 |
0.3 |
Preservative |
|
14 |
Distilled Water |
Up to 100 |
Up to 100 |
Up to 100 |
Vehicle |
Figure 1. Prepared nano-emulsion formulation
Figure 2: Homogenization of Nano-emulsion formulation
3.3. Procedure:
1. Weigh Sea Buckthorn oil, phosphatidylcholine, Tocopherol, and Rosemary Extract. Mix them under magnetic stirring (500 rpm, 5 min, 40-45°C) to ensure homogeneity.
2. Weigh Tween 80 (4%) + Span 80 (2%) and dissolve in propylene glycol and glycerol Heat gently (~40°C) to ensure complete mixing.
3. Slowly add the oil phase into the surfactant phase under high-speed homogenization (8000-10,000 rpm, 10 min).
4. Dissolve Xanthan Gum, Hydroxyethylcellulose, Citric Acid, Sodium Citrate, and preservatives (Ethylhexylglycerin and Phenoxyethanol) in distilled water up to 100%. Heat to 40-45°C while stirring.
5. Slowly add the aqueous phase into the oil-surfactant mixture under high-speed homogenization (10,000-12,000 rpm, 15-20 min). Further reduce droplet size using an ultra-sonicator (20 kHz, 5 min, pulse mode) for better stability.
6. Check pH and adjust if needed using citric acid/sodium citrate. Stir gently for 10 min to ensure uniformity.
4. EVALUATION OF SEA BUCKTHORN OIL NANO-EMULSION AND NANO-EMULSION GEL:
To determine their physicochemical stability, drug content uniformity, rheological behaviour, and drug release performance. These evaluation parameters ensure that the formulation is stable, effective, and suitable for topical drug delivery applications⁹,¹⁴.
4.1 Evaluation of Sea Buckthorn Oil Nano-emulsion:
4.1.1 Thermodynamic Stability Study:
Thermodynamic stability testing is performed to evaluate the physical stability of nano-emulsion formulations under stress conditions such as temperature variation and centrifugal force. Nano-emulsions are kinetically stable systems but may undergo instability phenomena such as creaming, coalescence, and phase separation when exposed to stress conditions. Heating–cooling cycles and centrifugation accelerate destabilization processes and help identify stable formulations¹⁷,¹⁶.
Importance:
Thermodynamic stability studies help identify formulations that can withstand environmental stress conditions during storage. These studies ensure long-term stability, maintain uniform droplet size distribution, and prevent drug precipitation or phase separation¹⁶.
Procedure:
Nano-emulsion formulations are subjected to temperature variations and
centrifugal forces to accelerate destabilization processes. These conditions
simulate long-term storage effects. The formulations are visually evaluated for
clarity, homogeneity, and absence of phase separation¹⁷.
4.1.2 pH Measurement:
The pH of nano-emulsion plays a critical role in maintaining drug stability and skin compatibility. It influences drug solubility, ionization, and formulation stability. Maintaining appropriate pH prevents irritation and ensures safe topical application¹³,¹⁸.
Importance: pH measurement ensures formulation safety, stability, and compatibility with the skin¹⁸.
Procedure:
The pH of nano-emulsion is determined using a calibrated digital pH meter after
dispersing the formulation in distilled water¹³.
4.1.3 Drug Content Determination:
Drug content determination quantifies the amount of drug present in nano-emulsion and ensures uniform distribution. Spectrophotometric analysis is commonly used to determine drug concentration and confirm formulation accuracy¹².
Importance: Ensures therapeutic effectiveness, formulation reproducibility, and quality control⁹.
Procedure:
The nano-emulsion is dissolved in a suitable solvent, and drug concentration is
measured using UV-Visible spectrophotometry based on calibration curve
analysis¹².
4.1.4 Transparency Measurement:
Transparency is an important indicator of nano-emulsion formation. Nano-emulsions appear transparent or translucent due to their nanoscale droplet size, which reduces light scattering¹⁴.
Importance: Confirms nano-range droplet size and formulation stability⁹.
Procedure: Transparency is determined by measuring light transmission using a spectrophotometer¹⁴.
4.1.5 Viscosity Measurement:
Viscosity determines the resistance of nano-emulsion to flow and affects formulation stability, drug release, and topical application behaviour⁶, ¹⁸.
Importance: Influences drug release rate, formulation stability, and ease of application⁶.
Procedure: Viscosity is measured using a viscometer.
4.1.6 Droplet Size and Polydispersity Index:
Droplet size significantly influences drug release, permeation, and stability. Smaller droplets provide larger surface area, improving drug delivery efficiency. Polydispersity index indicates uniformity of droplet size distribution¹⁴.
Importance: Uniform droplet size improves formulation stability, drug release, and skin penetration⁹.
Procedure: Measured using dynamic light scattering technique¹⁴.
4.1.7 Zeta Potential Measurement:
Zeta potential measures the electrical charge on droplet surface and indicates physical stability of nano-emulsion. Higher surface charge prevents aggregation¹⁶.
Importance: Predicts stability and ensures uniform dispersion¹⁶.
Procedure:
Measured using a zeta potential analyser based on electrophoretic
mobility⁹.
4.1.8 In-Vitro Diffusion Study:
In-vitro diffusion study evaluates drug release behaviour and predicts permeation performance¹³.
Importance: Determines therapeutic effectiveness and drug delivery efficiency⁹.
Procedure: Drug diffusion is evaluated using a diffusion membrane separating donor and receptor compartments, followed by spectrophotometric analysis¹³.
4.2 Evaluation of Sea Buckthorn Oil Nano-emulsion Gel:
4.2.1 Physical Appearance:
Physical examination evaluates homogeneity, consistency, and stability of gel formulation¹⁸.
Importance: Ensures uniform drug distribution and formulation stability.
Procedure: Gel is visually inspected for clarity, homogeneity, and absence of phase separation.
4.2.2 pH Measurement:
Importance: Ensures skin compatibility and formulation stability¹³.
Procedure: Gel is dispersed in distilled water and pH is measured using a digital pH meter.
4.2.3 Viscosity Measurement:
Importance: Determines gel consistency and drug release behaviour⁶.
Procedure: Measured using a viscometer.
4.2.4 Spreadability:
Importance: Ensures ease of application and uniform drug distribution¹⁸.
Procedure: Determined by evaluating gel spreading behaviour under applied force.
4.2.5 Drug Content Determination:
Importance: Ensures uniform drug distribution and therapeutic effectiveness¹².
Procedure: Drug is extracted and analysed using spectrophotometry.
4.2.6 In-Vitro Diffusion Study:
Importance: Evaluates drug release and permeation from gel formulation⁹.
Procedure: Drug release is evaluated using a diffusion membrane and receptor medium.
5. RESULTS AND EVALUATION OF SEA BUCKTHORN OIL NANO-EMULSION GEL:
Three formulations (F1, F2, and F3) containing different concentrations of sea buckthorn oil and propylene glycol were evaluated for physicochemical properties, stability, and drug release characteristics.
5.1 Physical Appearance:
Table 2. Physical Appearance
|
Formulation |
Colour |
Homogeneity |
Phase Separation |
Clarity |
|
F1 |
Light orange |
Homogeneous |
None |
Transparent |
|
F2 |
Orange |
Homogeneous |
None |
Transparent |
|
F3 |
Deep orange |
Homogeneous |
None |
Slightly translucent |
Interpretation:
All formulations showed uniform colour and homogeneity without any phase separation. The absence of instability indicates successful formation of nano-emulsion gel. The increase in colour intensity with increasing oil concentration confirms uniform incorporation of sea buckthorn oil.
5.2 pH Measurement:
Table 3: pH Measurement
|
Formulation |
pH (Mean±SD, n=3) |
|
F1 |
5.86±0.03 |
|
F2 |
5.94±0.02 |
|
F3 |
6.01±0.04 |
Interpretation:
The pH of all formulations was within the physiological skin pH range. The presence of citric acid and sodium citrate buffer system effectively maintained formulation pH stability. This ensures compatibility with skin and prevents irritation.
5.3 Viscosity Determination:
Table 4: Viscosity Determination
|
Formulation |
Viscosity (cP) (Mean ± SD) |
|
F1 |
18,450 ± 210 |
|
F2 |
19,820 ± 185 |
|
F3 |
21,360 ± 240 |
Interpretation:
Viscosity increased with increasing oil and propylene glycol concentration. The presence of xanthan gum and hydroxyethylcellulose contributed to gel formation and improved consistency. Proper viscosity ensures better topical retention and controlled drug release.
5.4 Droplet Size and Polydispersity Index:
Table 5. Droplet Size and Polydispersity Index
|
Formulation |
Droplet Size (nm) |
PDI |
|
F1 |
142.6 ± 5.3 |
0.312 ± 0.02 |
|
F2 |
158.4 ± 4.7 |
0.326 ± 0.01 |
|
F3 |
176.8 ± 6.1 |
0.348 ± 0.02 |
Interpretation:
All formulations showed droplet size in nano range. The increase in droplet size with oil concentration is expected due to increased internal phase volume. Low PDI values indicate uniform droplet size distribution and good stability.
5.5 Zeta Potential:
Table 6: Zeta Potential
|
Formulation |
Zeta Potential (mV) |
|
F1 |
−32.4 ± 1.8 |
|
F2 |
−34.7 ± 2.1 |
|
F3 |
−36.2 ± 1.9 |
Interpretation:
All formulations exhibited sufficient surface charge, indicating good electrostatic stability. The presence of phosphatidylcholine and surfactant blend contributed to stability.
5.6 Drug Content (Sea Buckthorn Oil Content
Table 7: Drug Content (Sea Buckthorn Oil Content
|
Formulation |
Drug Content (%) |
|
F1 |
97.82 ± 1.12 |
|
F2 |
98.94 ± 0.96 |
|
F3 |
99.36 ± 1.08 |
Interpretation:
All formulations showed uniform drug distribution. Slightly higher drug content in F3 confirms effective incorporation of higher oil concentration.
5.7 Spreadability:
Table 8: Spreadability
|
Formulation |
Spreadability (g·cm/sec) |
|
F1 |
16.42 ± 0.84 |
|
F2 |
15.86 ± 0.72 |
|
F3 |
14.93 ± 0.68 |
Interpretation:
Spreadability decreased slightly with increase in viscosity. However, all formulations showed good spreadability suitable for topical application.
5.8 Thermodynamic Stability Study
Table 9: Thermodynamic Stability Study
|
Formulation |
Heating–Cooling |
Centrifugation |
Stability Result |
|
F1 |
Stable |
Stable |
Passed |
|
F2 |
Stable |
Stable |
Passed |
|
F3 |
Stable |
Stable |
Passed |
Interpretation:
No phase separation or instability was observed, confirming thermodynamic stability of nano-emulsion gel.
5.9 In-Vitro Drug Release Study:
Table 10; In-Vitro Drug Release Study
|
Time (hr) |
F1 (%) |
F2 (%) |
F3 (%) |
|
1 |
18.4 |
21.2 |
24.6 |
|
2 |
32.6 |
36.8 |
41.3 |
|
4 |
54.8 |
60.2 |
66.7 |
|
6 |
71.4 |
76.5 |
82.3 |
|
8 |
85.6 |
89.2 |
93.8 |
Interpretation:
F3 showed highest drug release due to higher oil concentration and penetration enhancer. Nano-emulsion system improved drug diffusion and release performance.
6. CONCLUSION:
The present study successfully developed and systematically evaluated a sea buckthorn (Hippophae rhamnoides) oil-based nano-emulsion gel intended for topical drug delivery. Sea buckthorn oil was selected as the active component due to its rich content of bioactive constituents such as essential fatty acids, tocopherols, carotenoids, and phytosterols, which are known to contribute to antioxidant, anti-inflammatory, and skin-protective effects.
The nano-emulsion was formulated using a synergistic surfactant system consisting of Tween 80 and Span 80, along with phosphatidylcholine as a co-emulsifier and propylene glycol as a penetration enhancer. High-speed homogenization followed by ultrasonication enabled the formation of stable nano-sized droplets with uniform distribution. The incorporation of xanthan gum and hydroxyethylcellulose successfully converted the nano-emulsion into a gel system with suitable viscosity and application characteristics for topical use.
All developed formulations demonstrated desirable physicochemical properties, including acceptable pH within the physiological skin range, appropriate viscosity, and good spreadability. The droplet size of the formulations remained within the nanometer range with low polydispersity index, indicating uniform particle distribution and formulation stability. The negative zeta potential values confirmed sufficient electrostatic stabilization, preventing droplet aggregation. Drug content analysis showed uniform incorporation of sea buckthorn oil, confirming formulation consistency and reliability. Furthermore, thermodynamic stability studies revealed no signs of phase separation, creaming, or instability under stress conditions.
In-vitro drug release studies demonstrated sustained and efficient release of sea buckthorn oil from the nano-emulsion gel, with the optimized formulation (F3) showing the highest drug release profile. The enhanced release behaviour may be attributed to the nanoscale droplet size, increased surface area, and presence of penetration-enhancing components, which collectively facilitate improved drug diffusion.
In conclusion, the developed sea buckthorn oil nano-emulsion gel exhibited excellent physicochemical stability, uniform drug distribution, and favorable drug release characteristics, indicating its suitability as a topical delivery system. The findings suggest that nano-emulsion gel technology offers a promising approach for improving the topical delivery and therapeutic effectiveness of natural bioactive compounds, particularly for dermatological applications. Further studies, including in-vivo evaluation and long-term stability assessment, are recommended to confirm its clinical potential.
7. FUTURE PROSPECTS AND SCOPE OF RESEARCH:
The present study provides a strong foundation for further exploration of sea buckthorn oil nano-emulsion gel as an advanced topical drug delivery system. Although the current research has demonstrated successful formulation and evaluation, several opportunities exist to expand the scope and application of this delivery system.
Future research may focus on conducting ex-vivo skin permeation studies using animal or human skin models to evaluate the permeation efficiency and skin retention capability of the nano-emulsion gel. These studies will provide valuable insight into the penetration mechanism and therapeutic potential of the formulation.
In addition, in-vivo studies can be performed to evaluate the therapeutic effectiveness of the nano-emulsion gel in the treatment of various skin disorders such as wounds, burns, eczema, psoriasis, and inflammatory skin conditions. These studies will help establish clinical relevance and therapeutic benefits.
Advanced characterization techniques such as Transmission Electron Microscopy (TEM), Fourier Transform Infrared Spectroscopy (FTIR), Differential Scanning Calorimetry (DSC), and stability studies under accelerated and long-term storage conditions can further confirm formulation stability and compatibility.
Moreover, the nano-emulsion gel system can be explored as a carrier for other natural or synthetic therapeutic agents, including anti-inflammatory drugs, antimicrobial agents, and anticancer compounds, to improve their delivery efficiency.
The incorporation of targeted delivery approaches and nanocarrier modification strategies may further enhance drug localization, reduce systemic exposure, and improve therapeutic outcomes. Scale-up studies and industrial feasibility evaluation may also be conducted to support commercialization potential.
Thus, the developed nano-emulsion gel system offers a promising platform for future development of advanced topical formulations with improved efficacy, stability, and patient compliance
8. ACKNOWLEDGEMENT:
I would like to sincerely thank the principal and management of Shri Suresh Dada Jain College of Pharmacy, Jamner, for providing the necessary facilities, resources, and academic environment required for conducting this research work.
I extend my heartfelt appreciation to the faculty members and laboratory staff of the Department of Pharmaceutics for their cooperation, technical assistance, and encouragement during experimental work.
Finally, I acknowledge all those individuals who directly or indirectly contributed to the successful completion of this research work.
9. REFERENCES:
1. Sahu, P., Kashaw, S. K., Sau, S., and Iyer, A. K. Topical delivery systems for dermatological applications: Current trends and future perspectives. Drug Discovery Today. 2023; 28(3): 103487. https://doi.org/10.1016/j.drudis.2022.103487
2. Goyal, R., Macri, L. K., and Kohn, J. Nanoparticles and microneedles for enhanced transdermal drug delivery. Advanced Drug Delivery Reviews. 2022; 185: 114319. https://doi.org/10.1016/j.addr.2022.114319
3. Chen, J., Wei, N., Lopez-Garcia, M., and Li, M. Advances in lipid-based nanocarriers for topical drug delivery. Journal of Controlled Release. 2023; 354: 1–15. https://doi.org/10.1016/j.jconrel.2023.01.012
4. Khan, M. I., Hosseinzadeh, H., and Gopinath, P. Challenges and innovations in topical and transdermal drug delivery systems. Pharmaceutics. 2023; 15(2): 567. https://doi.org/10.3390/pharmaceutics15020567
5. Sharma, A., and Jain, S. Recent advances in nano-emulsion technology for transdermal applications. Colloids and Surfaces B: Biointerfaces. 2023; 221: 112987. https://doi.org/10.1016/j.colsurfb.2022.112987
6. Ghosh, V., Mukherjee, A., and Chandrasekaran, N. Formulation and evaluation of nano-emulsion drug delivery system. International Journal of Pharmaceutics. 2013; 452(1–2): 339–350. https://doi.org/10.1016/j.ijpharm.2013.04.028
7. Gupta, A., Mishra, V., and Singh, A. K. Challenges and innovations in nano-emulsion-based topical delivery systems. Pharmaceutics, 2024; 16(1): 45. https://doi.org/10.3390/pharmaceutics16010045
8. Kumar, R., Kumar, S., and Maheshwari, R. Nano-emulsion-based topical drug delivery system: A review. Journal of Drug Delivery and Therapeutics. 2021; 11(5): 150–162. https://doi.org/10.22270/jddt.v11i5.5031
9. Ye, R., Yang, J., and Prausnitz, M. R. Nano-emulsion-based delivery systems for improved skin absorption of therapeutics. Nature Reviews Materials. 2023; 8(3): 210–225. https://doi.org/10.1038/s41578-023-00584-8
10. Cortes, N., Alves, I. A., and Aragón, D. M. Innovative emulsifiers in cosmetic products: A patent review (2013–2023). ACS Omega. 2024; 9(50).
11. Kaur, H., Ahsan, M., and Jain, G. K. Development and optimization of sea buckthorn oil nano-emulsion for enhanced topical delivery: Stability and ex vivo permeation studies. Journal of Drug Delivery Science and Technology. 2023; 85: 104567.
12. Date, A. A., and Nagarsenker, M. S. Design and evaluation of microemulsions for improved drug delivery. AAPS PharmSciTech. 2007; 8(3): Article E1. https://doi.org/10.1208/pt0803021
13. De Silva, H. H. V. K. N., Abeywardana, Y. N. L., Pathirana, R. N., and Sanjeewani, N. A. Formulation, stability evaluation and characterization of Tween 80 consisting of neem oil-based emulsion. World Journal of Biology Pharmacy and Health Sciences. 2023; 13(1); 20–27.
14. Gupta, A., Eral, H. B., Hatton, T. A., and Doyle, P. S. Nano-emulsions: Formation, properties, and applications. Soft Matter. 2016; 12(11): 2826–2841. https://doi.org/10.1039/C5SM02958A
15. McClements, D. J. Nano-emulsions versus microemulsions: Terminology, differences, and similarities. Soft Matter. 2012; 8(6): 1719–1729. https://doi.org/10.1039/C2SM06903B
16. Tadros, T., Izquierdo, P., Esquena, J., and Solans, C. Formation and stability of nano-emulsions. Advances in Colloid and Interface Science. 2004; 108–109: 303–318. https://doi.org/10.1016/j.cis.2003.10.023
17. Shakeel, F., Ramadan, W., and Alsarra, I. A. Investigation of the stability of oil-in-water nano-emulsions containing different surfactants. Journal of Drug Delivery Science and Technology, 2009; 19(6): 389–397. https://doi.org/10.1016/S1773-2247(09)50068-3
18. Sinko, P. J. Martin’s Physical Pharmacy and Pharmaceutical Sciences (6th ed.). Lippincott Williams and Wilkins. 2011
19. Akhter, P., Bhatti, T. Y., Shafiq, I., et al. Antioxidant activity of sea buckthorn (Hippophae rhamnoides) seed oil extracted using various organic solvents. Korean Journal of Chemical Engineering, 2023; 40: 2914–2920.
20. Górnaś, P., Rudzińska, M., and Segliņa, D. Lipophilic bioactive compounds in sea buckthorn (Hippophae rhamnoides L.) oil: Composition and health benefits. Food Chemistry. 2023; 405: 134885. https://doi.org/10.1016/j.foodchem.2022.134885
21. Michel, T., Destandau, E., and Elfakir, C. Phytochemical diversity of sea buckthorn: A source of bioactive compounds for functional foods. Phytochemistry Reviews. 2023; 22(1): 45–67. https://doi.org/10.1007/s11101-022-09838-9
22. Suryakumar, G., and Gupta, A. Medicinal and therapeutic potential of sea buckthorn (Hippophae rhamnoides L.). Journal of Ethnopharmacology. 2023; 284: 114770. https://doi.org/10.1016/j.jep.2021.114770
23. Upadhyay, N. K., Kumar, R., and Mandotra, S. K. Sea buckthorn: A potential superfruit for nutraceutical and cosmeceutical applications. Trends in Food Science and Technology. 2024; 143: 104287. https://doi.org/10.1016/j.tifs.2023.104287
24. Zielińska, A., and Nowak, I. Fatty acid profile and antioxidant properties of sea buckthorn oils: A comparative study. Molecules. 2024; 29(2): 456. https://doi.org/10.3390/molecules29020456
25. Kumar, M., Dang, R., and Singh, K. Optimization of supercritical CO₂ extraction for sea buckthorn oil: Bioactive compounds and antioxidant activity. Food Chemistry. 2022; 368: 130876.
|
Received on 24.02.2026 Revised on 13.05.2026 Accepted on 11.07.2026 Published on 05.10.2026 Available online from October 12, 2026 Asian J. Res. Pharm. Sci. 2026; 16(4):339-348. DOI: 10.52711/2231-5659.2026.00050 ©Asian Pharma Press All Right Reserved
|
|
|
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Creative Commons License. |
|